Product logins

Find logins to all Clarivate products below.


PACS, RIS, and CVIS | Market Insights | US | 2021

With the increasing movement toward value-based health care, effective population health management, and continued hospital consolidation, the competitive field among vendors is largely being driven by enhancing interoperability, workflow management integration, patient and imaging data analysis through artificial intelligence, and storage between the PACS, RIS, and CVIS/CPACS solutions. However, market saturation driving increased price competition among vendors, health care system budgetary constraints, and an increasing shift toward enterprise solutions will limit market growth to a significant degree. The market will also be negatively affected in the short term by the global COVID-19 pandemic.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PACS, RIS, and CVIS in the US across a 10-year period.

Related Medtech Insights Reports

Report
PACS, RIS, and CVIS – Market Insights – United States
The US PACS, RIS, and CVIS market is projected to experience modest expansion through 2033. This growth is driven by the increasing rates of chronic illnesses in the US that drive radiology and…
Report
PACS, RIS, and CVIS – Market Insights – Europe
The European PACS, RIS, and CVIS market will continue to expand through 2032, despite the short-term negative impact of the COVID-19 pandemic, driven by Europe’s increasingly aging population,…
Report
PACS, RIS, and CVIS | Market Insights | US | 2023
The COVID-19 global pandemic has had a negative impact on the US PACS, RIS, and CVIS market, resulting in declines in unit sales and revenue in 2020. However, following a period of recovery,…
Report
Pulmonology Devices | Market Insights | US | 2021
​In 2020, the US pulmonology device market will be moderately impacted by the COVID-19 pandemic but will nevertheless grow over the forecast period, fueled by bronchoscopy procedure volume…
Report
Biosurgical Agents | Market Insights | Latin America | 2021
Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by …